323 related articles for article (PubMed ID: 11464194)
21. Cerebrotendinous xanthomatosis: early diagnosis on the basis of juvenile cataracts.
Tibrewal S; Duell PB; DeBarber AE; Loh AR
J AAPOS; 2017 Dec; 21(6):505-507. PubMed ID: 29079218
[TBL] [Abstract][Full Text] [Related]
22. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.
Nie S; Chen G; Cao X; Zhang Y
Orphanet J Rare Dis; 2014 Nov; 9():179. PubMed ID: 25424010
[TBL] [Abstract][Full Text] [Related]
23. [Cerebrotendinous xanthomatosis without tendinous xanthomas: presentation of two cases].
Campdelacreu J; Muñoz E; Cervera A; Jaumà S; Girós M; Tolosa E
Neurologia; 2002 Dec; 17(10):647-50. PubMed ID: 12487962
[TBL] [Abstract][Full Text] [Related]
24. Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene.
Suh S; Kim HK; Park HD; Ki CS; Kim MY; Jin SM; Kim SW; Hur KY; Kim KW; Kim JH
Eur J Med Genet; 2012 Jan; 55(1):71-4. PubMed ID: 21958693
[TBL] [Abstract][Full Text] [Related]
25. Cerebrotendinous xanthomatosis: a treatable neurodegenerative disease.
Sandeep P; Jayakrishnan C; Sadanan S; Sreekumar S; Thulasidharan NK
J Assoc Physicians India; 2009 Oct; 57():716-7. PubMed ID: 20329433
[TBL] [Abstract][Full Text] [Related]
26. Cerebrotendinous xanthomatosis: a case report.
Srinivas BH; Patnayak R; Rao IS; Prayaga A; Khan AK; Narasimhlu G
Acta Cytol; 2007; 51(4):654-6. PubMed ID: 17718147
[TBL] [Abstract][Full Text] [Related]
27. Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
Sasamura A; Akazawa S; Haraguchi A; Horie I; Ando T; Abiru N; Takei H; Nittono H; Une M; Kurosawa T; Murai T; Naruse H; Nakayama T; Kotani K; Remaley AT; Kawakami A
Intern Med; 2018 Jun; 57(11):1611-1616. PubMed ID: 29434128
[TBL] [Abstract][Full Text] [Related]
28. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.
DeBarber AE; Schaefer EJ; Do J; Ray JW; Larson A; Redder S; Fowler M; Duell PB
J Clin Lipidol; 2024; 18(3):e465-e476. PubMed ID: 38637260
[TBL] [Abstract][Full Text] [Related]
29. A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels.
Takahashi M; Okazaki H; Tada H; Ishibashi S
J Clin Lipidol; 2023; 17(6):834-838. PubMed ID: 37777472
[TBL] [Abstract][Full Text] [Related]
30. Cerebrotendinous xanthomatosis (a rare lipid storage disorder): a case report.
Razi SM; Gupta AK; Gupta DC; Gutch M; Gupta KK; Usman SI
J Med Case Rep; 2016 Apr; 10(1):103. PubMed ID: 27094915
[TBL] [Abstract][Full Text] [Related]
31. Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress.
Gonzalez-Cuyar LF; Hunter B; Harris PL; Perry G; Smith MA; Castellani RJ
Redox Rep; 2007; 12(3):119-24. PubMed ID: 17623518
[TBL] [Abstract][Full Text] [Related]
32. [Pathophysiology of cerebrotendinous xanthomatosis].
Koyama S; Kato T
Rinsho Shinkeigaku; 2016 Dec; 56(12):821-826. PubMed ID: 27840382
[TBL] [Abstract][Full Text] [Related]
33. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
Batta AK; Salen G; Tint GS
Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
[TBL] [Abstract][Full Text] [Related]
34. Cerebrotendinous xanthomatosis.
Berginer VM; Salen G; Shefer S
Neurol Clin; 1989 Feb; 7(1):55-74. PubMed ID: 2493565
[TBL] [Abstract][Full Text] [Related]
35. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.
Moghadasian MH
Clin Invest Med; 2004 Feb; 27(1):42-50. PubMed ID: 15061585
[TBL] [Abstract][Full Text] [Related]
36. [Cerebrotendinous xanthomatosis is a rare disorder, which requires a specific treatment].
Blaabjerg M; Marjanovic D
Ugeskr Laeger; 2013 Jan; 175(5):285-6. PubMed ID: 23369332
[TBL] [Abstract][Full Text] [Related]
37. Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.
Koyama S; Sekijima Y; Ogura M; Hori M; Matsuki K; Miida T; Harada-Shiba M
J Atheroscler Thromb; 2021 Sep; 28(9):905-925. PubMed ID: 33967188
[TBL] [Abstract][Full Text] [Related]
38. Cerebrotendinous xanthomatosis: a rare cause of spinocerebellar syndrome.
Ostrowska M; Banaszkiewicz K; Kiławiec A; Róg T; Lütjohann D; Szczudlik A
Neurol Neurochir Pol; 2011; 45(6):600-603. PubMed ID: 22212991
[TBL] [Abstract][Full Text] [Related]
39. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
[TBL] [Abstract][Full Text] [Related]
40. [Cerebrotendinous xanthomatosis. Report of one case].
Contreras JP; Guajardo G; Martínez A; López I; Cea G
Rev Med Chil; 2019 May; 147(5):658-662. PubMed ID: 31859899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
